Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1089 | 984 | 1089 | 1152 | 1145 | 1424 |
Fund Return | 8.85% | -1.62% | 8.85% | 4.83% | 2.74% | 3.59% |
Place in category | 118 | 101 | 118 | 73 | 245 | 160 |
% in Category | 28 | 28 | 28 | 21 | 73 | 79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DekaMultimanager ausgewogen Ante CF | 868.78M | 6.54 | -0.18 | - | ||
Deka-PB ManagerMandat | 782.98M | 9.43 | 0.09 | - | ||
LINGOHR-SYSTEMATIC-INVEST | 671.13M | 17.80 | 7.74 | 5.15 | ||
DekaStruktur: 5 ChancePlus | 383.64M | 16.37 | 2.50 | 6.78 | ||
PrivatDepot 2 (B) | 293.92M | 7.86 | 0.66 | 1.08 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Greater Europe Opportunities EUR Ac | 578.93M | -2.36 | -9.46 | 7.88 | ||
Greater Europe Opportunities EUR I | 578.93M | -1.88 | -9.00 | 8.42 | ||
Greater Europe Opportunities EUR R | 578.93M | -2.85 | -9.91 | 7.34 | ||
Aramea Aktien Select | 44.06M | 9.68 | 0.48 | 3.90 | ||
CHOM CAPITAL Active Return Europe U | 9.62M | -6.98 | -3.50 | 2.82 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 2.49 | 286.00 | +0.28% | |
Novo Nordisk B | DK0062498333 | 2.37 | 607.3 | +0.60% | |
Novartis | CH0012005267 | 2.08 | 95.58 | +1.90% | |
Carlsberg B | DK0010181759 | 2.00 | 754.6 | +0.59% | |
Holcim | CH0012214059 | 1.97 | 91.94 | 0.00% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review